Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Goldfischer

Affiliations

  • Director at Epizyme Inc. (EPZM), 2019-06-07
  • Director at Cymabay Therapeutics Inc. (CBAY), 2019-02-09
  • Director at Enteromedics Inc (ETRM), 2017-05-31
  • Director at Poniard Pharmaceuticals Inc. (PARD), 2011-06-10
  • Director at Map Pharmaceuticals Inc. (MAPP), 2010-05-21
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EPZM $9.00 10,389 Director 3,380,951 2016-01-12 Filing
EPZM $9.00 545,166 Director 3,370,562 2016-01-12 Filing
EPZM $15.00 3,117 Large Shareholder, Director 3,658,729 2013-06-05 Filing
EPZM $15.00 163,549 Large Shareholder, Director 3,655,612 2013-06-05 Filing
ETRM $1.65 17,724 Large Shareholder, Director 103,484 2011-09-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CBAY $9.02 11,675 Director 0 2019-02-07 Filing
CBAY $13.03 15,000 Director 0 2018-03-22 Filing
CBAY $8.66 18,000 Director 0 2017-11-02 Filing
ETRM $4.85 97 Director 0 2017-05-25 Filing
ETRM $4.85 4,571 Director 0 2017-05-25 Filing